USFDA classifies cGMP inspection of Cipla's Virgonagar facility as VAI

08 Feb 2025

USFDA classifies cGMP inspection of Cipla's Virgonagar facility as VAI

Cipla has classified its current Good Manufacturing Practices (cGMP) inspection of the company's manufacturing facility in Virgonagar, Bengaluru, conducted between 7 ' 13 November 2024, as Voluntary Action Indicated (VAI).

Top Blogs

blog-article-image-one

Share Market

Low Price Shares

0 mins read . Dec 18, 2024

blog-article-image-one

Share Market

Nifty 50 Top 10 Stocks

0 mins read . Dec 18, 2024

blog-article-image-one

Share Market

Best Stocks in 2025

0 mins read . Dec 18, 2024

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions